de Vries-Sluijs, T E M S <br/><br/>
Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.  [electronic resource] 

 -  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology  May 2006 
 - 60-3 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1386-6532 
<br/><br/><label>Standard No.: </label>10.1016/j.jcv.2005.12.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>DNA, Viral--blood<br/>Drug Resistance, Viral--genetics<br/>Genetic Variation<br/>HIV Infections--complications<br/>Hepatitis B--complications<br/>Hepatitis B virus--drug effects<br/>Humans<br/>Kinetics<br/>Lamivudine--therapeutic use<br/>Male<br/>Middle Aged<br/>Organophosphonates--therapeutic use<br/>RNA, Viral--blood<br/>Tenofovir